Cargando…

Top Evidentiary Gaps in Managed Care Pharmacy: A Research Agenda

Research agendas play valuable roles in clearly identifying high-priority topics that reflect potential to improve health care quality. The purpose of this report is to present work completed by the Academy of Managed Care Pharmacy (AMCP) and AMCP Foundation Joint Research Committee. This committee...

Descripción completa

Detalles Bibliográficos
Autores principales: Gembarski, Jody, Couto, Joseph, Wilson, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391282/
https://www.ncbi.nlm.nih.gov/pubmed/32130069
http://dx.doi.org/10.18553/jmcp.2020.19372
_version_ 1785082671930540032
author Gembarski, Jody
Couto, Joseph
Wilson, Marcus
author_facet Gembarski, Jody
Couto, Joseph
Wilson, Marcus
author_sort Gembarski, Jody
collection PubMed
description Research agendas play valuable roles in clearly identifying high-priority topics that reflect potential to improve health care quality. The purpose of this report is to present work completed by the Academy of Managed Care Pharmacy (AMCP) and AMCP Foundation Joint Research Committee. This committee set forth to develop a research agenda for our 2 organizations that focuses on critical evidence needs in managed care pharmacy. This document reviews results from 2 surveys that were conducted to better understand unmet research needs within managed care pharmacy and to inform professional efforts of managed care pharmacists. The first survey collected qualitative data from key opinion leaders (KOLs) regarding the top evidentiary gaps in managed care pharmacy and barriers to closing those gaps. The second survey was sent to AMCP members and AMCP Foundation stakeholders, used a mixed methods quantitative-qualitative design, and incorporated concepts from initial KOL responses. The key outcome from these proceedings is the research agenda, which identifies and prioritizes 4 evidentiary gaps in managed care pharmacy: (1) real-world evidence to inform managed care pharmacy decision making, (2) value-based models in managed care pharmacy to address total cost of care, (3) impact of benefit design or utilization management strategies on patient outcomes, and (4) impact of direct patient care services provided by managed care pharmacy on patient outcomes. The agenda was intended to be broad and will evolve over time. AMCP and the AMCP Foundation hope that this research agenda inspires the AMCP membership, researchers, and funding agencies to close these gaps in knowledge and understanding.
format Online
Article
Text
id pubmed-10391282
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-103912822023-08-02 Top Evidentiary Gaps in Managed Care Pharmacy: A Research Agenda Gembarski, Jody Couto, Joseph Wilson, Marcus J Manag Care Spec Pharm Proceedings Research agendas play valuable roles in clearly identifying high-priority topics that reflect potential to improve health care quality. The purpose of this report is to present work completed by the Academy of Managed Care Pharmacy (AMCP) and AMCP Foundation Joint Research Committee. This committee set forth to develop a research agenda for our 2 organizations that focuses on critical evidence needs in managed care pharmacy. This document reviews results from 2 surveys that were conducted to better understand unmet research needs within managed care pharmacy and to inform professional efforts of managed care pharmacists. The first survey collected qualitative data from key opinion leaders (KOLs) regarding the top evidentiary gaps in managed care pharmacy and barriers to closing those gaps. The second survey was sent to AMCP members and AMCP Foundation stakeholders, used a mixed methods quantitative-qualitative design, and incorporated concepts from initial KOL responses. The key outcome from these proceedings is the research agenda, which identifies and prioritizes 4 evidentiary gaps in managed care pharmacy: (1) real-world evidence to inform managed care pharmacy decision making, (2) value-based models in managed care pharmacy to address total cost of care, (3) impact of benefit design or utilization management strategies on patient outcomes, and (4) impact of direct patient care services provided by managed care pharmacy on patient outcomes. The agenda was intended to be broad and will evolve over time. AMCP and the AMCP Foundation hope that this research agenda inspires the AMCP membership, researchers, and funding agencies to close these gaps in knowledge and understanding. Academy of Managed Care Pharmacy 2020-04 /pmc/articles/PMC10391282/ /pubmed/32130069 http://dx.doi.org/10.18553/jmcp.2020.19372 Text en Copyright © 2020, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Proceedings
Gembarski, Jody
Couto, Joseph
Wilson, Marcus
Top Evidentiary Gaps in Managed Care Pharmacy: A Research Agenda
title Top Evidentiary Gaps in Managed Care Pharmacy: A Research Agenda
title_full Top Evidentiary Gaps in Managed Care Pharmacy: A Research Agenda
title_fullStr Top Evidentiary Gaps in Managed Care Pharmacy: A Research Agenda
title_full_unstemmed Top Evidentiary Gaps in Managed Care Pharmacy: A Research Agenda
title_short Top Evidentiary Gaps in Managed Care Pharmacy: A Research Agenda
title_sort top evidentiary gaps in managed care pharmacy: a research agenda
topic Proceedings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391282/
https://www.ncbi.nlm.nih.gov/pubmed/32130069
http://dx.doi.org/10.18553/jmcp.2020.19372
work_keys_str_mv AT gembarskijody topevidentiarygapsinmanagedcarepharmacyaresearchagenda
AT coutojoseph topevidentiarygapsinmanagedcarepharmacyaresearchagenda
AT wilsonmarcus topevidentiarygapsinmanagedcarepharmacyaresearchagenda
AT topevidentiarygapsinmanagedcarepharmacyaresearchagenda